Latest Insider Transactions at Boston Scientific Corp (BSX)
This section provides a real-time view of insider transactions for Boston Scientific Corp (BSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BOSTON SCIENTIFIC CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BOSTON SCIENTIFIC CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,990
-1.05%
|
$129,350
$65.95 P/Share
|
|
Feb 14
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
4,362
+2.26%
|
-
|
|
Feb 14
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
939
-1.57%
|
$61,035
$65.95 P/Share
|
|
Feb 14
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,115
+3.42%
|
-
|
|
Feb 14
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,328
-0.44%
|
$476,320
$65.95 P/Share
|
|
Feb 14
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,523
+0.99%
|
-
|
|
Feb 14
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,266
-1.71%
|
$82,290
$65.95 P/Share
|
|
Feb 14
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,776
+3.62%
|
-
|
|
Feb 14
2024
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
488
-1.32%
|
$31,720
$65.95 P/Share
|
|
Feb 14
2024
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,057
+2.78%
|
-
|
|
Feb 14
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
965
-1.95%
|
$62,725
$65.95 P/Share
|
|
Feb 14
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,115
+4.1%
|
-
|
|
Feb 14
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,378
-4.82%
|
$89,570
$65.95 P/Share
|
|
Feb 14
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,379
+7.69%
|
-
|
|
Feb 13
2024
|
Edward J Ludwig Director |
SELL
Open market or private sale
|
Direct |
7,000
-14.47%
|
$455,000
$65.03 P/Share
|
|
Feb 13
2024
|
Edward J Ludwig Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+12.64%
|
$119,000
$17.37 P/Share
|
|
Feb 12
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Bona fide gift
|
Indirect |
550
+10.1%
|
-
|
|
Feb 12
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
6,000
-3.15%
|
-
|
|
Feb 06
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,262
-5.84%
|
-
|
|
Feb 06
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
36,666
+11.64%
|
-
|
|
Feb 06
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
9,722
-25.77%
|
-
|
|
Feb 06
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Grant, award, or other acquisition
|
Direct |
22,666
+37.53%
|
-
|
|
Feb 06
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
7,983
-12.16%
|
-
|
|
Feb 06
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+21.52%
|
-
|
|
Feb 06
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
16,450
-7.95%
|
-
|
|
Feb 06
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Grant, award, or other acquisition
|
Direct |
33,332
+13.88%
|
-
|
|
Feb 06
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
11,579
-30.65%
|
-
|
|
Feb 06
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+34.62%
|
-
|
|
Feb 06
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
65,047
-3.82%
|
-
|
|
Feb 06
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
146,666
+7.94%
|
-
|
|
Feb 06
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
12,160
-14.61%
|
-
|
|
Feb 06
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Grant, award, or other acquisition
|
Direct |
26,666
+24.26%
|
-
|
|
Feb 06
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
5,472
-10.36%
|
-
|
|
Feb 06
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+18.52%
|
-
|
|
Jan 12
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
11,660
-6.3%
|
$699,600
$60.0 P/Share
|
|
Jan 09
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
15,172
-21.14%
|
$895,148
$59.25 P/Share
|
|
Jan 09
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
15,172
+17.45%
|
$242,752
$16.31 P/Share
|
|
Jan 04
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
15,000
-20.95%
|
$870,000
$58.4 P/Share
|
|
Jan 04
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+17.32%
|
$240,000
$16.31 P/Share
|
|
Jan 03
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
11,931
-17.41%
|
$680,067
$57.82 P/Share
|
|
Jan 01
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,199
-3.28%
|
$467,343
$57.81 P/Share
|
|
Jan 01
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,979
+8.75%
|
-
|
|
Jan 01
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
6,733
-30.89%
|
$383,781
$57.81 P/Share
|
|
Jan 01
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
14,823
+40.47%
|
-
|
|
Jan 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
5,380
-10.14%
|
$306,660
$57.81 P/Share
|
|
Jan 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
11,772
+18.16%
|
-
|
|
Jan 01
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
10,908
-5.56%
|
$621,756
$57.81 P/Share
|
|
Jan 01
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
21,799
+10.01%
|
-
|
|
Jan 01
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
40,104
-2.51%
|
$2,285,928
$57.81 P/Share
|
|
Jan 01
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
95,919
+5.67%
|
-
|